For example, TRIM24 was able to boost the ER, AR, and STAT3 pathways in breast, prostate and brain cancers, respectively [128,129,130], in addition to targeting wtp53 for degradation in breast cancer [94]. The gene discussed is AR; the disease is breast carcinoma.